BlackRock, Inc. 13D and 13G filings for Veracyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-08 4:32 pm Purchase | 2024-06-30 | 13G | Veracyte, Inc. VCYT | BlackRock Inc. BLK | 7,793,059 10.200% | 631,193 (+8.81%) | Filing |
| 2024-01-24 5:23 pm Purchase | 2023-12-31 | 13G | Veracyte, Inc. VCYT | BlackRock Inc. BLK | 7,161,866 9.800% | 627,297 (+9.60%) | Filing |
| 2023-01-25 10:36 am Purchase | 2022-12-31 | 13G | Veracyte, Inc. VCYT | BlackRock Inc. BLK | 6,534,569 9.100% | 261,016 (+4.16%) | Filing |
| 2022-02-03 4:29 pm Purchase | 2021-12-31 | 13G | Veracyte, Inc. VCYT | BlackRock Inc. BLK | 6,273,553 8.800% | 992,578 (+18.80%) | Filing |
| 2021-02-01 08:30 am Purchase | 2020-12-31 | 13G | Veracyte, Inc. VCYT | BlackRock Inc. BLK | 5,280,975 9.100% | 970,441 (+22.51%) | Filing |
| 2020-02-06 09:10 am Purchase | 2019-12-31 | 13G | Veracyte, Inc. VCYT | BlackRock Inc. BLK | 4,310,534 8.800% | 1,328,865 (+44.57%) | Filing |